Exercise Decreases Anti-Mullerian Hormone in Anovulatory Overweight Women with Polycystic Ovary Syndrome - A Pilot Study

被引:33
|
作者
Moran, L. J. [1 ]
Harrison, C. L. [1 ]
Hutchison, S. K. [1 ,2 ]
Stepto, N. K. [3 ]
Strauss, B. J. [4 ,5 ,6 ]
Teede, H. J. [1 ,2 ]
机构
[1] Monash Univ, Jean Hailes Fdn Womens Hlth Res Unit, Sch Publ Hlth & Prevent Med, Clayton, Vic, Australia
[2] So Hlth, Diabet Unit, Clayton, Vic, Australia
[3] Victoria Univ, Inst Sport Exercise & Act Living, Clayton, Vic, Australia
[4] Monash Univ, Dept Med, Clayton, Vic, Australia
[5] Monash Univ, Dept Nutr, Clayton, Vic, Australia
[6] Monash Univ, Dept Dietet, Clayton, Vic, Australia
关键词
REPRODUCTIVE AGE; OBESE WOMEN; WEIGHT-LOSS;
D O I
10.1055/s-0031-1291208
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Polycystic ovary syndrome (PCOS) is a common condition in women associated with menstrual irregularity and anovulation. While obesity worsens and weight loss or exercise improves reproduction function in PCOS, the mechanism for this is unclear. The aim of this study was to examine the effect of exercise on ovarian hormones [anti-Mullerian hormone (AMH)] and menstrual and ovulatory function in women with and without PCOS. Overweight women with (n = 7) and without (n = 8) PCOS of comparable age, weight and BMI undertook a 12-week intensified endurance exercise training program (1 h 3 times/week) with no structured energy restriction. Primary outcomes were AMH, ovulation (weekly urinary pregnanediol) and menstrual regularity. Secondary outcomes were insulin resistance (euglycemic hyperinsulinemic clamp) and body composition (computed tomography and dual X-ray absorptiometry). Exercise decreased BMI, total and android fat mass and improved insulin sensitivity for all women. AMH was significantly higher in women with PCOS compared to controls before (p < 0.001) and after exercise (p = 0.001). There was a significant interaction between AMH changes with exercise and PCOS status (p = 0.007) such that women without PCOS had no change in AMH (+1.4 +/- 5.2 pmol/l, p = 0.48) while women with PCOS had a decrease in AMH (-13.2 +/- 11.7 pmol/l, p = 0.025). Exercise is associated with improvements in ovarian hormones in women with abnormal ovarian function. This suggests that mechanisms associated with ovarian dysfunction can be improved by exercise in PCOS.
引用
收藏
页码:977 / 979
页数:3
相关论文
共 50 条
  • [1] Anti-Mullerian hormone and polycystic ovary syndrome
    Lebkowska, Agnieszka
    Kowalska, Irina
    ENDOKRYNOLOGIA POLSKA, 2017, 68 (01) : 74 - 78
  • [2] Anti-Mullerian hormone and polycystic ovary syndrome
    Catteau-Jonard, S.
    Dewailly, D.
    GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2011, 39 (09): : 514 - 517
  • [3] The value of measuring anti-Mullerian hormone in women with anovulatory polycystic ovary syndrome undergoing laparoscopic ovarian diathermy
    Amer, S. A.
    Li, T. C.
    Ledger, W. L.
    HUMAN REPRODUCTION, 2009, 24 (11) : 2760 - 2766
  • [4] Role of anti-Mullerian hormone in polycystic ovary syndrome
    Bhattacharya, Koushik
    Saha, Ishita
    Sen, Debanjana
    Bose, Chaitali
    Chaudhuri, Gargi Ray
    Dutta, Sulagna
    Sengupta, Pallav
    Bhattacharya, Soumita
    Barman, Sharit Shekhar
    Syamal, Alak Kumar
    MIDDLE EAST FERTILITY SOCIETY JOURNAL, 2022, 27 (01)
  • [5] Role of anti-Mullerian hormone in polycystic ovary syndrome
    Koushik Bhattacharya
    Ishita Saha
    Debanjana Sen
    Chaitali Bose
    Gargi Ray Chaudhuri
    Sulagna Dutta
    Pallav Sengupta
    Soumita Bhattacharya
    Sharit Shekhar Barman
    Alak Kumar Syamal
    Middle East Fertility Society Journal, 27
  • [6] Anti-Mullerian hormone in patients with polycystic ovary syndrome
    Chebotnikova, T.
    Ilyin, A.
    Melnichenko, G.
    Chernukha, G.
    GIORNALE ITALIANO DI OSTETRICIA E GINECOLOGIA, 2012, 34 (01): : 140 - 140
  • [7] Sibutramine administration decreases serum anti-Mullerian hormone (AMH) levels in women with polycystic ovary syndrome
    Vosnakis, Christos
    Georgopoulos, Neoklis A.
    Armeni, Anastasia K.
    Papadakis, Efstathios
    Roupas, Nikolaos D.
    Katsikis, Ilias
    Panidis, Dimitrios
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2012, 163 (02) : 185 - 189
  • [8] Dysregulation of the Anti-Mullerian Hormone System by Steroids in Women With Polycystic Ovary Syndrome
    Pierre, Alice
    Taieb, Joelle
    Giton, Frank
    Grynberg, Michael
    Touleimat, Salma
    El Hachem, Hady
    Fanchin, Renato
    Monniaux, Danielle
    Cohen-Tannoudji, Joelle
    di Clemente, Nathalie
    Racine, Chrystele
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (11): : 3970 - 3978
  • [9] Anti-Mullerian hormone levels in peripubertal daughters of women with polycystic ovary syndrome
    Crisosto, Nicolas
    Codner, Ethel
    Maliqueo, Manuel
    Echiburu, Barbara
    Sanchez, Fernando
    Cassorla, Fernando
    Sir-Petermann, Teresa
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (07): : 2739 - 2743
  • [10] Anti-Mullerian Hormone and Polycystic Ovary Syndrome in Women and Its Male Equivalent
    di Clemente, Nathalie
    Racine, Chrystele
    Rey, Rodolfo A.
    BIOMEDICINES, 2022, 10 (10)